We are live on
!
Find out more
MCM
Massar Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
14.18%
This Fund
S&P 500
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+14.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.9M
AUM Growth
–
Cap. Flow
+$88.7M
Cap. Flow
% of AUM
100.83%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$9.69M |
| 2 |
Illumina
ILMN
|
+$8.55M |
| 3 |
TKO Group
TKO
|
+$6.37M |
| 4 |
United Therapeutics
UTHR
|
+$4.82M |
| 5 |
US Foods
USFD
|
+$3.77M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.5% |
| 2 | Technology | 17.29% |
| 3 | Industrials | 11.75% |
| 4 | Communication Services | 10.75% |
| 5 | Consumer Staples | 8.52% |
Similar funds
TS
NI
TW
PWAM
FPI
APM
NM
PGA
Massar Capital Management's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Massar Capital Management, which disclosed 47 positions worth $87.9M. Its ten largest holdings account for 54% of the portfolio.
Its largest position is Moderna: 202,674 shares worth $8.43M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, followed by Technology and Industrials.
- Massar Capital Management's largest Q4 2024 buy was Moderna: 202,674 shares worth $8.43M.
- Massar Capital Management's ten largest holdings make up 54% of its $87.9M portfolio in Q4 2024.
- Massar Capital Management disclosed 47 positions in Q4 2024, its first 13F filing on record.
Based on Massar Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.